A Randomized, Open-Label, Parallel Group Study to Evaluate the Efficacy and Safety of Proactive Management in Pediatric Subjects with Moderate to Severe Atopic Dermatitis

被引：0
|
作者：
Fukuie, Tatsuki [1 ,2 ]
Nomura, Ichiro [3 ]
Narita, Masami [2 ]
Suzuki, Tsukasa [1 ]
Tajima, Iwao [1 ]
Natsume, Osamu [1 ]
Taguchi, Tomohide [1 ]
Ogata, Tsutomu [1 ]
Tokura, Yoshiki [4 ]
Matsumoto, Kenji [3 ]
Ohya, Yukihiro [2 ]
机构：
[1] Hamamatsu Univ Sch Med, Dept Pediat, Shizuoka, Japan
[2] Natl Ctr Child Hlth & Dev, Dept Med Subspecialties, Div Allergy, Tokyo, Japan
[3] Natl Res Inst Child Hlth & Dev, Dept Allergy & Immunol, Tokyo, Japan
[4] Hamamatsu Univ Sch Med, Dept Dermatol, Shizuoka, Japan
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2013年 / 131卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2012.12.1030
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：AB101 / AB101
页数：1
相关论文
共 50 条
  • [21] Winning Poster: A Phase 2, Open-Label, Investigator-Initiated Study to Evaluate the Safety and Efficacy of Apremilast in Subjects with Recalcitrant Contact or Atopic Dermatitis
    Volf, Eva
    [J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2011, 10 (08) : 928 - 928
  • [22] Randomized, Open-Label, Parallel Group Study to Evaluate the Effect of Internet-Based Glucose Management System on Subjects with Diabetes in China
    Kim, Hun-Sung
    Sun, Chenglin
    Yang, So Jung
    Sun, Lin
    Li, Fei
    Choi, In Young
    Cho, Jae-Hyoung
    Wang, Guixia
    Yoon, Kun-Ho
    [J]. TELEMEDICINE AND E-HEALTH, 2016, 22 (08) : 666 - 674
  • [23] Efficacy and safety of switching from dupilumab to upadacitinib in moderate-to-severe atopic dermatitis: results from an open-label extension trial
    Blauvelt, A.
    Ladizinski, B.
    Prajapati, V. H.
    Laquer, V.
    Fischer, A.
    Eisman, S.
    Wu, T.
    Vigna, N.
    Teixeira, H. D.
    Liu, J.
    Eyerich, K.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E142 - E142
  • [24] An open-label phase IIa trial assessing the pharmacokinetics, safety and efficacy of dupilumab in a paediatric population with moderate-to-severe atopic dermatitis
    Cork, M. J.
    Thaci, D.
    Davis, J. D.
    Zhang, Q.
    Akinlade, B.
    Graham, N. M. H.
    Pirozzi, G.
    Bansal, A.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 : 155 - 155
  • [25] An open-label phase IIa trial assessing the pharmacokinetics, safety and efficacy of dupilumab in a paediatric population with moderate-to-severe atopic dermatitis
    Cork, M. J.
    Thaci, D.
    Davis, J. D.
    Zhang, Q.
    Akinlade, B.
    Graham, N. M. H.
    Pirozzi, G.
    Bansal, A.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 : 67 - 68
  • [26] A phase 3 open-label, randomized multicenter study to evaluate efficacy and safety of secukinumab in pediatric patients with moderate to severe plaque psoriasis: 24-week results
    Magnolo, Nina
    Kingo, Kulli
    Laquer, Vivian
    Browning, John
    Reich, Adam
    Szepietowski, Jacek C.
    Keefe, Deborah
    Mazur, Rafal
    Ghelani, Prayashi
    Forrer, Pascal
    Wraith, LindaAnn
    Patekar, Manmath
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 86 (01) : 122 - 130
  • [27] Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study
    Deleuran, Mette
    Thaci, Diamant
    Beck, Lisa A.
    de Bruin-Weller, Marjolein
    Blauvelt, Andrew
    Forman, Seth
    Bissonnette, Robert
    Reich, Kristian
    Soong, Weily
    Hussain, Iftikhar
    Foley, Peter
    Hide, Michihiro
    Bouaziz, Jean-David
    Gelfand, Joel M.
    Sher, Lawrence
    Schuttelaar, Marie L. A.
    Wang, Chen
    Chen, Zhen
    Akinlade, Bolanle
    Gadkari, Abhijit
    Eckert, Laurent
    Davis, John D.
    Rajadhyaksha, Manoj
    Staudinger, Heribert
    Graham, Neil M. H.
    Pirozzi, Gianluca
    Ardeleanu, Marius
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (02) : 377 - 388
  • [28] Methotrexate and azathioprine in severe atopic dermatitis: a randomized controlled trial and open-label extension study
    Roekevisch, E.
    Schram, M. E.
    Gerbens, L. A. A.
    Hamann, S. A. S.
    Leeflang, M. M. G.
    Brouwer, M. W. D.
    Bos, J. D.
    Spuls, P. I.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (01) : E45 - E45
  • [29] Dupilumab in Adults With Moderate to Severe Atopic Dermatitis A 5-Year Open-Label Extension Study
    Beck, Lisa A.
    Bissonnette, Robert
    Deleuran, Mette
    Nakahara, Takeshi
    Galus, Ryszard
    Coleman, Anna
    Gherardi, Guy
    Xiao, Jing
    Dingman, Robert
    Xu, Christine
    Avetisova, Elena
    Dubost-Brama, Ariane
    Shabbir, Arsalan
    [J]. JAMA DERMATOLOGY, 2024, 160 (08) : 805 - 812
  • [30] Proactive versus Rank-Down Topical Corticosteroid Therapy for Maintenance of Remission in Pediatric Atopic Dermatitis: A Randomized, Open-Label, Active-Controlled, Parallel-Group Study (Anticipate Study)
    Kamiya, Koji
    Saeki, Hidehisa
    Tokura, Yoshiki
    Yoshihara, Shigemi
    Sugai, Junichi
    Ohtsuki, Mamitaro
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (21)
12345